Stephanie Monaghan O'brien - Net Worth and Insider Trading

Stephanie Monaghan O'brien Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephanie Monaghan O'brien owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of Stephanie Monaghan O'brien’s form 4 insider trades.

Insider Ownership Summary of Stephanie Monaghan O'brien

Ticker	Company	Transaction Date	Type of Owner
APLS	Apellis Pharmaceuticals Inc	2017-11-08	director

Stephanie Monaghan O'brien Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephanie Monaghan O'brien Ownership Network

Ownership Network List of Stephanie Monaghan O'brien

No Data

Ownership Network Relation of Stephanie Monaghan O'brien

Stephanie Monaghan O'brien Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Stephanie Monaghan O'brien is the director of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include General Counsel David O. Watson , See Remarks James George Chopas , and Senior Vice President Mark Jeffrey Delong .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Stephanie Monaghan O'brien made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 232,500 shares made by Pascal Deschatelets , a net sale of 36,864 shares made by David O. Watson , and a net sale of 18,850 shares made by Mark Jeffrey Delong .

In summary, during the past 3 months, insiders sold 5,000 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 797,890 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 797,890 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Stephanie Monaghan O'brien Mailing Address

Above is the net worth, insider trading, and ownership report for Stephanie Monaghan O'brien. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephanie Monaghan O'brien's mailing address is: Newton Centre Ma 02459.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.